More tools:Markets·Screener·Research·Chat

Opko Health Inc. (OPK) Financial Statements

Opko Health Inc.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SD4254
XNAS · usd
1.59▼ 0.05 (-3.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.64
Day's Range1.54 – 1.63
52-Week Range0.98 – 1.73
Volume2.6M
Avg Volume4.2M
Share Statistics
Shares Outstanding
Employees2,275
ExchangeXNAS
Listed1995-11-02
Share count as of July 17, 2026
Loading Income Statement…
Key questions about Opko Health Inc. (OPK)
What is Opko Health Inc.'s Market Cap?
Opko Health Inc.'s Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s Enterprise Value?
Opko Health Inc.'s Enterprise Value is $892.6M, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s Price / Sales?
Opko Health Inc.'s Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s EV / Revenue?
Opko Health Inc.'s EV / Revenue is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s EV / EBITDA?
Opko Health Inc.'s EV / EBITDA is 21.5×, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s Revenue (TTM)?
Opko Health Inc.'s Revenue (TTM) is $587.9M, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s Net Income (TTM)?
Opko Health Inc.'s Net Income (TTM) is -$72.9M, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s EBITDA?
Opko Health Inc.'s EBITDA is $41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s Diluted EPS (TTM)?
Opko Health Inc.'s Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.
What is Opko Health Inc.'s EBITDA Margin?
Opko Health Inc.'s EBITDA Margin is 7.1%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Revenues——
YoY growth+4.3%-17.2%——
Costs and expenses:
Cost of Goods and Services Sold——
Selling, general and administrative——
Research and development
Amortization of intangible assets——
Total costs and expenses——
% of revenue104.3%141.1%——
Operating loss
% of revenue-4.3%-41.1%——
Other income (expense), net:
Interest income
Interest expense
Fair value changes of derivative instruments, net——
Other income (expense), net——
Other expense, net——
Loss before income taxes and investment losses——
Income tax benefit
Net loss before investment losses——
Net loss
% of revenue-5.1%-44.2%——
Loss per share, basic—
Loss per share, diluted—